Connect your AI

Scholar Rock SRRK Debt Issuance Costs

Debt Issuance Costs at other companies

Edgewise Therapeutics, Inc.EWTX

$38K—

Dyne Therapeutics, Inc.DYN

$30K—

Arrowhead ResearchARWR

$18.72M—

BioCryst PharmaceuticalsBCRX

$4.95M—

Denali Therapeutics Inc.DNLI

$81K—

Ligand PharmaceuticalsLGND

$50K-29.6%

Other financials

Income statement

Revenue-—

Operating income-$102.0M-32.3%

Net income-$105.5M-41.2%

EPS (diluted)-$0.83-23.9%

Balance sheet

Cash & equivalents$430.5M+212%

Total debt$205.7M+226%

Total equity$276.0M-11.6%

Total assets$535.3M+31.3%

Cash flow

Operating cash flow-$82.1M-4.4%

CapEx$68.0K-74.9%

Free cash flow-$82.2M-4.1%

Valuation

Market cap$6.14B+85.5%

Profitability

Operating margin-231.8%—

Net margin-236.9%—

FCF margin-309.1%—

Returns & leverage

Return on equity-138.9%+60.1pp

Debt / equity0.7×+0.5×

Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Scholar Rock's debt issuance costs?: Scholar Rock (SRRK) reported debt issuance costs of $1.31M in Q1 2026.
What does debt issuance costs mean?: Cash paid for fees, legal costs, and underwriting discounts associated with issuing new debt.